hotspot -WSS

hotspot

author：entertainment 2025-09-29 16:35:55 - browse：389

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

LEXINGTON, Mass. — New obesity drugs like Wegovy and Zepbound are currently taken once a week, indefinitely. But what if they could be taken once a year instead, like a vaccine?

That’s a question that Novo Nordisk, the pharma company behind Wegovy, is exploring as it faces increased competition from other drugmakers aiming to develop similar GLP-1-based treatments for obesity.

“We have a very early think tank on: what would it take us, from a technology point of view and from an ecosystem point of view, to make long-lasting GLP-1 molecules?” Marcus Schindler, Novo’s chief scientific officer, said in an interview with STAT Wednesday. “Could we think about vaccine-like properties, where imagine you had, once a year, an injection with an equivalent of a GLP-1 that really helps you to maintain weight loss and have cardiovascular benefits?”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： In science, is the line between industry and academia shifting?

WSS

NYU Langone launches private ChatGPT for its health care data

Is there an 'orca uprising'? Like orcas themselves, the answer is complex.

Russia's threat to pull out of Ukraine grain deal raises fears about global food security

Superbugs, antibiotic resistance get scrutiny in congress

AstraZeneca challenges Medicare drug negotiation program

NYU Langone launches private ChatGPT for its health care data

explore

hotspot

hotspot

Heart attack and stroke risk calculators need revising

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

Alkermes shareholders re

AstraZeneca challenges Medicare drug negotiation program

As demand for Covid shots wanes, Moderna seeks its next success

Grail's uphill battle for Medicare to cover its cancer screening test

Heart attack and stroke risk calculators need revising

How are insurers handling Leqembi and related scans?

How one medical school became remarkably diverse

Cuban government calls US nuclear submarine stop a 'provocative escalation'

entertainment

Feds fine Medicare Advantage plans for overcharging members

How to make AI work for medicine

Vermont grapples with historic flooding as more rainstorms head for Northeast

How a symptom of dementia informs our understanding of creativity

Tommy Tuberville reverses his claim that white nationalists are unfairly labeled racist

Psilocybin's anti

Wikipedia

hotspot

Wikipedia

explore